Sandoz Group AG (LON:0SAN)

London flag London · Delayed Price · Currency is GBP · Price in CHF
46.94
-1.28 (-2.64%)
At close: Jul 31, 2025
-2.64%
Market Cap18.74B
Revenue (ttm)8.29B
Net Income (ttm)n/a
Shares Outn/a
EPS (ttm)n/a
PE Ration/a
Forward PE17.16
Dividend0.55 (1.15%)
Ex-Dividend DateApr 17, 2025
Volume66,582
Average Volume63,587
Open47.70
Previous Close48.22
Day's Range46.69 - 47.76
52-Week Range26.99 - 48.43
Betan/a
RSI63.06
Earnings DateAug 7, 2025

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1886
Employees 22,049
Stock Exchange London Stock Exchange
Ticker Symbol 0SAN
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.